Mouse Monoclonal TLR9 Antibody (26C593.2)
Applications | FC, IHC, WB |
Reactivities | Human, Mouse, Rat, Canine, Equine, Primate |
Conjugation | Unconjugated |
Mouse Monoclonal TLR9 Antibody (26C593.2)
Applications | FC, IHC, WB |
Reactivities | Human, Mouse, Rat, Canine, Equine, Primate |
Conjugation | Unconjugated |
Mouse Monoclonal TLR3 Antibody (40C1285.6)
Applications | FC, IHC, WB |
Reactivities | Human, Mouse, Canine |
Conjugation | Unconjugated |
Recombinant Anti-CD3 epsilon (Clone UCHT1)
Applications | FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
Applications | FC |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD34 (Clone My10)
Applications | FC, IHC, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD4 (Clone YNB46.1.8 (Campath-9H))
Applications | FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-HLA class II (Clone F3.3)
Applications | FC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
USD 523.00
5 Weeks
Recombinant Anti-IL-2R (Clone Daclizumab)
Applications | FC |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-IL-2R (Clone Daclizumab)
Applications | FC |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
USD 523.00
2 Weeks
Recombinant Anti-IL-2R alpha (CD25) (Clone Basiliximab)
Applications | FC, IF, IHC, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-IL-2R alpha (CD25) (Clone Basiliximab)
Applications | FC, IF, IHC, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD19 (Clone HD37)
Applications | FC, IF, IHC, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone MT310)
Applications | FC, IF, IHC, IP, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Recombinant Anti-CD19 (Clone 4G7)
Applications | FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone 13B8.2)
Applications | EIA, ELISA, FC, IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD33 (Clone hP67.6 (Gemtuzumab))
Applications | FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD30 (Clone Ki-4)
Applications | ELISA, FC, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
Applications | Bl, FC, IP |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Recombinant Anti-CD64 (Clone H22)
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL2R (Clone AHT107)
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-IL2R (Clone AHT54)
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone DB81)
Applications | ELISA, FC, Neutralize |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD20 (Clone CAT-13.6E12)
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD10 (Clone FR4D11)
Applications | FC, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD1a (Clone CBT6)
Applications | ELISA, FC, IHC, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD8 (Clone RIV11)
Applications | FC, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD74 (Clone LN-2)
Applications | ELISA, FC, IF, IHC, IP, WB |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Recombinant Anti-CD74 (Clone LL1 (EPB1))
Applications | FC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-PD-L1 (Clone 332M7)
Applications | FC |
Reactivities | Human, Monkey, Mouse |
Conjugation | Unconjugated |